New Report: RSV’s Hidden Burden on Pediatric Primary Care
Association Excellence in Pediatrics Institute
Empowering pediatricians through education, research, and collaboration to improve child health globally.
While RSV is well-known for overwhelming hospitals during peak seasons, its real and often underreported toll begins in primary care and private practices. The Excellence in Pediatrics Institute, with support from Sanofi, conducted an in-depth assessment to highlight the unseen burden, challenges, and opportunities to improve RSV diagnosis, treatment, and prevention, where care starts—at the community level.
Primary care physicians and private pediatricians are often the first to encounter RSV cases. This survey uncovered a rising trend in both the volume and severity of RSV cases in infants and young children. From prolonged symptoms and hospitalizations to disrupted daycare and family life, the impact extends beyond the clinic, putting pressure on already strained practices and communities.
Primary care physicians and private pediatricians are often the first to encounter RSV cases. This survey uncovered a rising trend in both the volume and severity of RSV cases in infants and young children.
The RSV Impact Assessment Survey reveals the scale and complexity of RSV’s burden across frontline care settings.
Infants at Highest Risk
Infants and children suffer disproportionately from RSV, with higher hospitalization rates and prolonged recovery.
Diagnosis Still Lags Behind
Underuse of lab testing leaves many RSV cases unconfirmed, complicating both care and public health tracking.
Prevention - Action
While prevention awareness is widespread among pediatricians, recommendations for vaccination remain inconsistent.
Call for Better Education
Most physicians expressed a strong need for updated clinical guidelines and hands-on training sessions.